Tizanidine
- Product NDC
- 16714-171
- 11-digit product format
- 167140171
- Labeler code
- 16714
- Product ID
- 16714-171_a9995022-1f3f-f0dd-9672-60b074bfca01
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NorthStar Rx LLC
- Application
- ANDA076286
- Marketing category
- ANDA
- Marketing start
- 2021-06-15
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 313412, 313413 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 16714-171-01 | Tizanidine | 150 in 1 BOTTLE | TABLET | 150 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 16714-171 | TIZANIDINE TABLET [NORTHSTAR RX LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20231227_eed74219-9d4a-fecd-1bb9-ad6c01ad3e9d.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-171-01 | 16714017101 | 150 TABLET in 1 BOTTLE (16714-171-01) | 150 tablet | 2021-06-15 | 0000-00-00 | No | No | Current |